Insider Selling: Omada Health (NASDAQ:OMDA) CEO Sells $356,895.44 in Stock

Omada Health, Inc. (NASDAQ:OMDA) CEO Sean Duffy sold 17,258 shares of the business’s stock in a transaction on Thursday, October 1st. The shares were sold at an average price of $20.68, for a total transaction of $356,895.44. Following the transaction, the chief executive officer owned 382,594 shares in the company, valued at approximately $7,912,043.92. This represents a 4.32% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Omada Health Trading Up 0.8%

Shares of NASDAQ:OMDA opened at $20.89 on Thursday. Omada Health, Inc. has a 1 year low of $10.28 and a 1 year high of $26.92. The business has a fifty day simple moving average of $21.84 and a 200 day simple moving average of $18.82. The firm has a market cap of $1.28 billion, a price-to-earnings ratio of 417.80 and a beta of 2.03.

Omada Health (NASDAQ:OMDA) last issued its earnings results on Thursday, August 6th. The company reported $0.08 EPS for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.10. Omada Health had a return on equity of 2.60% and a net margin of 1.39%.The firm had revenue of $87.83 million for the quarter, compared to the consensus estimate of $80.93 million. On average, sell-side analysts forecast that Omada Health, Inc. will post 0.09 EPS for the current year.

Institutional Trading of Omada Health

Several large investors have recently made changes to their positions in OMDA. Walleye Capital LLC bought a new position in shares of Omada Health in the 2nd quarter valued at approximately $11,648,000. Quantinno Capital Management LP boosted its position in Omada Health by 464.1% during the first quarter. Quantinno Capital Management LP now owns 58,723 shares of the company’s stock worth $738,000 after purchasing an additional 48,313 shares during the period. GSA Capital Partners LLP acquired a new position in Omada Health during the second quarter valued at approximately $1,289,000. AlpInvest Partners B.V. acquired a new position in Omada Health during the second quarter valued at approximately $1,182,000. Finally, BlackRock Inc. bought a new position in shares of Omada Health in the second quarter valued at approximately $48,775,000.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the company. Citigroup reissued an “outperform” rating on shares of Omada Health in a research note on Friday, August 14th. JPMorgan Chase & Co. raised their price objective on shares of Omada Health from $26.00 to $30.00 and gave the company an “overweight” rating in a research report on Friday, August 14th. Wall Street Zen cut shares of Omada Health from a “buy” rating to a “hold” rating in a research note on Saturday, October 3rd. Robert W. Baird boosted their target price on shares of Omada Health from $15.00 to $25.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 12th. Finally, Barclays increased their price target on shares of Omada Health from $25.00 to $27.00 and gave the stock an “overweight” rating in a research note on Friday, September 11th. Eleven equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $26.67.

Omada Health Company Profile

Omada Health, Inc is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines connected health devices, digital tools, health coaching and clinical support to help members improve their health and manage conditions such as diabetes, hypertension and musculoskeletal disorders.

The company’s services are designed for employers, health plans and other healthcare organizations seeking to support populations with ongoing healthcare needs.